INFOGRAFHICS: Generic and innovative drugs market in Central Europe 2018

More information on this topic is presented in the PMR report:

In Bulgaria, the sales of original medicines will be boosted by the appearance of innovative preparations on reimbursement lists, along with the possibility that GPs may be able to prescribe drugs for certain diseases without the need for patient consultation with a specialist. The Czech Republic will be the slowest market in the area of innovative drug sales. Recent years have been very fragile. The Czech government is trying to cut the costs of medicines for which the insurance companies pay and which put a strain on the insured party. The government’s more pro-generic policy and expiring patents all constitute additional obstacles for the development of the innovative medicine market and can even prompt the withdrawal of drugs from the market.

 


More information on this topic is presented in the PMR report:
Generic and innovative drugs market in CE 2018. Market analysis and development forecasts for 2018-2023